Dosing Interval Study of SST-0225 Topical Ibuprofen Cream in the Treatment of Delayed Onset Muscle Soreness

Completed · Phase 2 · Has a placebo group

Conditions studied: Delayed Onset Muscle Soreness

In brief

This is a Phase 2, prospective, randomized, dual-center, double-blind, placebo-controlled, parallel-group study designed to determine the dosing interval, efficacy and safety of SST-0225 (5.4 grams, applied up to 6 times in 24 hours, over a 48-hour dosing period) for the treatment of pain associated with DOMS.

Key facts

Study ID
NCT02339129
Run by
Strategic Science & Technologies, LLC
People needed
72
Starts
2014-11-01
Expected to finish
2015-03-01
Last updated by the study team
2016-09-09

Who can join

Age: 16 and older, up to 65. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.